Chambal Q1: JV loss drags consolidated PAT to ₹524 Cr (-5% YoY); core up ~7%, margins expand

Consolidated net profit for Q1 FY27 came in at ₹523.6 Cr, down 4.6% from ₹548.9 Cr a year earlier, on revenue of ₹5,027 Cr that fell 11.8% YoY. The headline decline is misleading: it is entirely attributable to the Moroccan phosphate joint venture (IMACID), whose equity-accounted share swung to a ₹25.1 Cr loss this quarter from a ₹36.1 Cr profit a year ago — a ~₹61 Cr YoY drag. Strip the JV out and consolidated PAT actually rose ~7% YoY. The sequential surge (PAT up 209% from ₹169 Cr in Q4) is a seasonality artifact — Q1 captures the kharif fertiliser season against a structurally weak Q4 — and should not be read as a step-change.

Beneath the topline dip, the core business strengthened. Net margin expanded to 10.4% from 9.6% a year ago, and segment profit before finance costs and tax rose 11% YoY to ₹778.9 Cr even as every segment's revenue fell. Complex Fertilisers was the standout — profit up 67% to ₹238.7 Cr on revenue down 18% — while Crop Protection profit rose 13% to ₹108.4 Cr, both signs of pricing/mix discipline over volume. Standalone tells a cleaner version of the same story: PAT of ₹703.5 Cr, up 10.3% YoY, with PBT up 10% to ₹926.6 Cr; the >15-point gap between standalone (+10%) and consolidated (-5%) growth is the JV, which only enters the group numbers. Finance costs jumped to ₹16.8 Cr from ₹2.4 Cr, reflecting borrowings for the Technical Ammonium Nitrate (TAN) plant and brownfield capex now moving through the P&L.

The stock went into the print at ₹443, down 6.2% over the past month of trading.

On the last (Q4 FY26) call management flagged that near-term urea volumes would be dented by a plant shutdown while FY27 volumes should still exceed FY26, and pointed to the new TAN plant (targeting 75-80% utilisation) plus high-margin Crop Protection as growth engines. Q1 is consistent with that framing: Own Manufactured Fertilisers (largely urea) revenue fell 8% YoY, while the TAN-housing 'Others' segment is still negligible (₹0.05 Cr result) as it commissions — the FY27 volume-beat and TAN ramp remain to be proven in coming quarters. No published Street consensus for Q1 FY27 was available at the time of writing (no brokerage preview surfaced). The board separately set August 11, 2026 as the dividend record date; results carry an unmodified limited-review conclusion. The company gives no formal quarterly guidance beyond the qualitative FY27 outlook above.